Viewing nowNewsig 10 mg (Dapagliflozin Propanediol Monohydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

MFDS item code 202202198 · Approved 2022.05.24 · Insurance code 644503340
Improvement of blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood glucose levels in patients with type 2 diabetes. It can be used alone or in combination with other medications alongside dietary and exercise therapy. It is specifically used in patients with cardiovascular disease or risk factors who do not have sufficient blood glucose control. This medication plays an important role in diabetes management by helping with blood glucose control. For adverse reactions and precautions, please refer to the guidance of a healthcare professional. Overall, it is effectively used in the treatment of type 2 diabetes.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other blood glucose-lowering agents, such as insulin. When this medicine is used with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of treatment with diabetes medications, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in certain patients. For example, patients with allergies to the active ingredient or excipients, those with type 1 diabetes, patients with diabetic ketoacidosis, patients with lactose intolerance or specific genetic issues, and patients undergoing dialysis should not take this medication. It should be administered cautiously to patients with reduced fluid volume or renal function issues. This medication may lower blood pressure or affect kidney function, so blood pressure and renal function should be closely monitored before and during administration. Special care is needed for the elderly or patients taking diuretics. Taking this medication may cause genital infections or urinary tract infections, and immediate treatment should be sought if infection symptoms occur. Additionally, hypoglycemia may occur, and dosage adjustment may be necessary to reduce the risk of hypoglycemia if taking medications like insulin or sulfonylureas. This medication can induce a reduction in fluid volume, and if symptoms of dehydration or hypotension occur, a temporary cessation of administration may be discussed with a physician. There is also a risk of serious metabolic disorders known as diabetic ketoacidosis, so careful monitoring for related symptoms or risk factors is essential. Patients with impaired liver function or the elderly must also take care when using this medication and should understand that glucose may be detected in urine tests during treatment. Pregnant or breastfeeding women are advised not to use this medication. The safety and efficacy in children have not yet been established. As there is no specific antidote in case of overdose, appropriate treatment should be administered according to symptoms, and measures should be taken per a physician's instructions if necessary. Finally, this medication does not significantly affect the ability to drive or operate machinery; however, caution should be exercised regarding the risk of hypoglycemia when combined with other antidiabetic agents. Store the medication out of the reach of children and keep it in its original container for safety.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, elevated blood creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, biliary stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, chest pain, paresthesia, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, somnolence, headache, nasopharyngitis, upper respiratory infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, itching, urticaria, sweating, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is safe to keep it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness.
Yellow, double convex diamond-shaped film-coated tablets
28 tablets/box [(28 tablets (7 tablets/PTP x 4)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.